Insmed Incorporated (INSM): Among Billionaire George Soros' Mid-Cap Stocks With Huge Upside Potential

We recently published a list of Billionaire George Soros’ 10 Mid-Cap Stocks With Huge Upside Potential. In this article, we are going to take a look at where Insmed Incorporated (NASDAQ:INSM) stands against other billionaire George Soros’ mid-cap Stocks with huge upside potential.

George Soros is one of the most successful investors in the stock market’s history. He founded the Soros Fund Management, which currently manages over $6.6 billion in assets. His fund often makes contrarian moves that catch the attention of Wall Street and retail investors alike. Alex Soros, one of George Soros’ sons from his second marriage, was handed over the reins in 2023.

When investors like George Soros invest in companies, they usually have solid reasons to do so. This is why keeping an eye on their holdings is so important. We decided to take a look at George Soros’ Mid-Cap stock holdings to see what mid-cap stocks he is betting on.

To come up with our list of billionaire George Soros’ 10 Mid-Cap stocks with huge upside potential, we first looked at his top 50 stock holdings. We then filtered out the companies between $10 billion and $40 billion in market cap.

After arriving at his top mid-cap holdings list, we then looked at the median analyst price targets on those stocks and then ranked them by their upside potential. We have also mentioned the hedge fund sentiment as per Insider Monkey’s database of Q4 2024.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

Insmed Incorporated (NASDAQ:INSM)

Soros Fund Management’s Stake Value: $31.4 Million

Number of Hedge Fund Holders: 72

Insmed Incorporated operates as a marketer and developer of therapies for patients with rare and serious diseases. The company’s stock has tripled in less than a year, thanks mainly to the success of its lung disease drug brensocatib. In fact, the stock doubled in a single day back in May last year when the company reported an early-stage success related to its development.

There is reason to believe that brensocatib will continue to drive future returns for the company. It received a Priority Review from the FDA back in February, with a target action date of 12th August 2025. This will significantly reduce the time it takes to bring the drug to the market.

Once the drug eventually becomes approved and available, it will be the only approved medication for bronchiectasis on the market! The condition affects nearly half a million people in the US, with a similar number of sufferers in Europe and Japan combined. Clearly, there’s a lot of potential here and George Soros sees that with his $31.4 million stake in the company. According to the median analyst price target, the stock still has an upside of 39.55%.

Overall, INSM ranks 7th on our list of billionaire George Soros’ mid-cap Stocks with huge upside potential. While we acknowledge the potential of INSM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than INSM but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.